Drug Database
Back to search

Switzerland· 48942040

Retrovir AZT 250 mg, Kapseln

A zidovudine product containing zidovudinum, registered in Switzerland by ViiV Healthcare GmbH and dispensed under Swissmedic category A, on the national reimbursement list. The same ATC class is registered in 15 of our 19 countries.

Reimbursed in Switzerland (BAG SL)Cat A (Swissmedic)ATC J05AF01

Checked against Swissmedic (Switzerland) on

Informational only — not a medical device.

SOURCE REGISTER · CHSwissmedic (Switzerland)normalisedRetrovir AZT 250 mg, KapselnATCJ05AF01REGISTER NO.48942040PACKS LISTED1CHECKEDSeptember 12, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about zidovudinumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Zidovudine is registered in 15 of 19 countries.

Countries holding a registration under ATC J05AF01 (zidovudine), each read from that country’s own register.

  • This record: Switzerland, from Swissmedic (Switzerland)
  • 8 of them publish a price we can compare per daily dose
Search zidovudine products by name

Zidovudine · ATC J05AF01

15 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of zidovudine costs, country by country.

Normalised to the WHO defined daily dose (0.6 g), so markets compare like for like.

  • Switzerland: $10.96 per daily dose (median across products in the class)
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Zidovudine · price per daily dose (0.6 g)

USD · FX 28 Sept 2026

  • CH Switzerland$10.96
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

Swissmedic (Switzerland)
Active substance
zidovudinum
Manufacturer
ViiV Healthcare GmbH
Country
Switzerland (CH)
ATC code
J05AF01
ATC class
Zidovudine
Defined daily dose
0.6 g, O
Swissmedic category
A
Reimbursed
Yes
Source register
Swissmedic (Switzerland)
Last checked
September 12, 2026

Packs & prices · 1

1 priced
  • gtin
    7680489420402
    40 Stk
    CHF 151.55

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

321 interactions on record for zidovudine.

Graded by severity as the source publishes them — 36 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check zidovudine against other medicinesHow interaction checks work

Zidovudine · interactions on record

321 records

  • 36 severe
  • 220 moderate
  • 9 minor
  • 55 info

Most severe, free to view

  • CladribineL01BB04severe
  • BexaroteneL01XF03severe
  • BexarotenL01XX25severe
  • Amphotericin BA07AA07moderate

1 more interaction with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Zidovudine in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All zidovudine products

Authorised across Europe · EMA

The same active substance is authorised in 20 EEA countries. Names it is sold under:

  • Austria · Retrovir
  • Belgium · Retrovir, Retrovir I.V.
  • Bulgaria · Ретровир
  • Czechia · Retrovir
  • Germany · Retrovir, Retrovir I.V.
  • Denmark · Retrovir
  • Estonia · Retrovir
  • Spain · Retrovir, Zidovudina Accord
  • Finland · Retrovir
  • France · Retrovir
  • United Kingdom (Northern Ireland) · Retrovir, Retrovir Iv
  • Greece · Retrovir
  • Ireland · Retrovir
  • Italy · Retrovir
  • Luxembourg · Retrovir, Retrovir I.V.
  • Netherlands · Retrovir, Retrovir Infuus
  • Poland · Retrovir
  • Portugal · Retrovir, Retrovir Iv
  • Romania · Retrovir
  • Sweden · Retrovir

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swissmedic (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/0bfe7a1f-1765-4c8f-b844-f8acda5bef2a
GET /v1/drugs/0bfe7a1f-1765-4c8f-b844-f8acda5bef2a?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "unit": null,
  "strength": "zidovudinum 250 mg",
  "valid_from": "1990-03-15",
  "limitations": null,
  "galenic_form": "Kaps 250 mg",
  "therapeutic_area": null,
  "sl_inclusion_date": "1990-03-15",
  "self_retention_pct": 10
}
API referenceMCP serverPlans

See everything about zidovudine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console